1. #link("https://livermetabolism.com/paper/Gerhaeusser2024_spt_model.pdf")[#fa-icon("file-pdf")] *Simulation of zonation-function relationships in the liver using coupled multiscale models: Application to drug-induced liver injury*. Steffen Gerhäusser, Lena Lambers, Luis Mandl, Julian Franquinet, Tim Ricken, *Matthias König*; bioRxiv 2024.03.26.586870;, #link("https://doi.org/10.1101/2024.03.26.586870")[10.1101/2024.03.26.586870]
2. #link("https://livermetabolism.com/paper/StemmerMallol2023_talinolol.pdf")[#fa-icon("file-pdf")]#link("https://github.com/matthiaskoenig/talinolol-model.git")[#fa-icon("git-alt")] *Insights into Intestinal P-glycoprotein Function using Talinolol: A PBPK Modeling Approach*. Beatrice Stemmer Mallol, Jan Grzegorzewski, *Matthias König*; bioRxiv 2023.11.21.568168, #link("https://doi.org/10.1101/2023.11.21.568168")[10.1101/2023.11.21.568168]
3. #link("https://livermetabolism.com/paper/Kuettner2023_chlorzoxazone.pdf")[#fa-icon("file-pdf")]#link("https://github.com/matthiaskoenig/chlorzoxazone-model")[#fa-icon("git-alt")] *A physiologically based pharmacokinetic model for CYP2E1 phenotyping via chlorzoxazone*. J. Küttner, J. Grzegorzewski, HM. Tautenhahn, *M. König*; bioRxiv 2023.04.12.536571, #link("https://doi.org/10.1101/2023.04.12.536571")[10.1101/2023.04.12.536571]
4. #link("https://livermetabolism.com/paper/Bartsch2023_simvastatin.pdf")[#fa-icon("file-pdf")]#link("https://github.com/matthiaskoenig/simvastatin-model")[#fa-icon("git-alt")] *Simvastatin therapy in different subtypes of hypercholesterolemia - a physiologically based modelling approach*. F. Bartsch, J. Grzegorzewski, H. Pujol, HM. Tautenhahn, *M. König*; medRxiv 2023.02.01.23285358, #link("https://doi.org/10.1101/2023.02.01.23285358")[10.1101/2023.02.01.23285358]
